Cargando…

Connecting the dots between SHP2 and glutamate receptors

SHP2 is an unusual protein phosphatase that functions as an activator for several signaling pathways, including the RAS pathway, while most other phosphatases suppress their downstream signaling cascades. The physiological and pathophysiological roles of SHP2 have been extensively studied in the fie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ryu, Hyun-Hee, Kim, Sun Yong, Lee, Yong-Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Physiological Society and The Korean Society of Pharmacology 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043995/ https://www.ncbi.nlm.nih.gov/pubmed/32140036 http://dx.doi.org/10.4196/kjpp.2020.24.2.129

Ejemplares similares

Protein-protein interaction between caveolin-1 and SHP-2 is dependent on the N-SH2 domain of SHP-2
por: Park, Hyunju, et al.
Publicado: (2015)

Functions of Shp2 in cancer
por: Zhang, Jie, et al.
Publicado: (2015)

Orphan nuclear receptor SHP regulates iron metabolism through inhibition of BMP6-mediated hepcidin expression
por: Kim, Don-Kyu, et al.
Publicado: (2016)

The Orphan Nuclear Receptor SHP Is a Positive Regulator of Osteoblastic Bone Formation
por: Jeong, Byung-Chul, et al.
Publicado: (2010)

Connecting Dots between Mitochondrial Dysfunction and Depression
por: Khan, Mehtab, et al.
Publicado: (2023)

Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors
por: Xu, Xiaozheng, et al.
Publicado: (2021)

Selective inhibition of leukemia-associated SHP2(E69K) mutant by the allosteric SHP2 inhibitor SHP099
por: Sun, X, et al.
Publicado: (2018)

Regulation of Nasal Airway Homeostasis and Inflammation in Mice by SHP-1 and Th2/Th1 Signaling Pathways
por: Cho, Seok Hyun, et al.
Publicado: (2014)

SHP-2 in Lymphocytes' Cytokine and Inhibitory Receptor Signaling
por: Niogret, Charlène, et al.
Publicado: (2019)

PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2
por: Xu, Xiaozheng, et al.
Publicado: (2020)

Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies
por: Song, Zhendong, et al.
Publicado: (2021)

Glutamate, Glutamate Receptors, and Downstream Signaling Pathways
por: Willard, Stacey S., et al.
Publicado: (2013)

Shp2 Knockdown and Noonan/LEOPARD Mutant Shp2–Induced Gastrulation Defects
por: Jopling, Chris, et al.
Publicado: (2007)

Intraarticular injection of SHP2 inhibitor SHP099 promotes the repair of rabbit full-thickness cartilage defect
por: Sun, Ziying, et al.
Publicado: (2022)

The function of Shp2 tyrosine phosphatase in the dispersal of acetylcholine receptor clusters
por: Qian, Yueping K, et al.
Publicado: (2008)

Connecting the dots
por: Carta, Antonio
Publicado: (2017)

Connecting the Dots
por: Collective
Publicado: (2016)

Sidestepping SHP2 inhibition
por: Popescu, Bogdan, et al.
Publicado: (2023)

Reversal agents for NOACs: Connecting the dots
por: Dalal, Jamshed, et al.
Publicado: (2016)

Alopecia and Periodontitis: Exploring the connecting dots
por: Agrawal, Jaya, et al.
Publicado: (2023)

Growth Factors, and Cytokines; Understanding the Role of Tyrosine Phosphatase SHP2 in Gametogenesis and Early Embryo Development
por: Idrees, Muhammad, et al.
Publicado: (2020)

Connecting the Dots between PubMed Abstracts
por: Hossain, M. Shahriar, et al.
Publicado: (2012)

Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors
por: Franciosa, Giulia, et al.
Publicado: (2023)

SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses
por: Christofides, Anthos, et al.
Publicado: (2022)

Destabilization of the SHP2 and SHP1 protein tyrosine phosphatase domains by a non-conserved “backdoor” cysteine
por: Yarnall, Matthew T.N., et al.
Publicado: (2022)

Strategies to overcome drug resistance using SHP2 inhibitors
por: Liu, Meng, et al.
Publicado: (2021)

Connecting the Dots: Interplay of Pathogenic Mechanisms between COVID-19 Disease and Mucormycosis
por: Prakash, Hariprasath, et al.
Publicado: (2021)

Relationship between Zinc (Zn(2+)) and Glutamate Receptors in the Processes Underlying Neurodegeneration
por: Pochwat, Bartłomiej, et al.
Publicado: (2015)

Cross-Regulation of Protein Stability by p53 and Nuclear Receptor SHP
por: Yang, Zhihong, et al.
Publicado: (2012)

SHP2 mutations induce precocious gliogenesis of Noonan syndrome-derived iPSCs during neural development in vitro
por: Ju, Younghee, et al.
Publicado: (2020)

Glutamate transporters: The arrestin connection
por: Zafra, Francisco, et al.
Publicado: (2016)

Inhibition of SHP2 and SHP1 Protein Tyrosine Phosphatase Activity by Chemically Induced Dimerization
por: Buck, Sara J. S., et al.
Publicado: (2022)

Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2
por: Taylor, Julia, et al.
Publicado: (2023)

Simulation-Based Cybersecurity Testing and Evaluation Method for Connected Car V2X Application Using Virtual Machine
por: Lee, Dae-Hwi, et al.
Publicado: (2023)

The Role of Glutamate Receptors in Epilepsy
por: Chen, Tsang-Shan, et al.
Publicado: (2023)

New Insights into Orphan Nuclear Receptor SHP in Liver Cancer
por: Zou, An, et al.
Publicado: (2015)

Differential Methylation Pattern of ID4, SFRP1, and SHP1 between Acute Myeloid Leukemia and Chronic Myeloid Leukemia
por: Uhm, Kyung-Ok, et al.
Publicado: (2009)

Effects of tranexamic acid on the activity of glutamate transporter EAAT3
por: Shin, Hyun-Jung, et al.
Publicado: (2020)

The Tyrosine Phosphatase SHP2: A New Target for Insulin Resistance?
por: Saint-Laurent, Céline, et al.
Publicado: (2022)

SHP2: A Pleiotropic Target at the Interface of Cancer and Its Microenvironment
por: Sodir, Nicole M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vdk4a3t94o31jd19v1vtnul5i5